Comparative analysis of beneficial effects of vancomycin treatment on Th1- and Th2-biased mice and the role of gut microbiota - PubMed (original) (raw)

. 2021 Apr;130(4):1337-1356.

doi: 10.1111/jam.14853. Epub 2020 Sep 30.

Affiliations

Comparative analysis of beneficial effects of vancomycin treatment on Th1- and Th2-biased mice and the role of gut microbiota

P Ray et al. J Appl Microbiol. 2021 Apr.

Abstract

Aims: The aim was to understand the time-dependent antibiotic-induced perturbation pattern of gut microbiota and its effect on the innate immune and metabolic profile of the host.

Methods and results: Vancomycin was administered at 50 mg kg-1 of body weight twice daily for six consecutive days to perturb the gut microbiota of C57BL/6 (Th1-biased) and BALB/c (Th2-biased) mice. Following treatment with vancomycin, we observed a reduction in the abundance of phyla Firmicutes and Bacteroides and an increase in Proteobacteria in the gut for both strains of mice following treatment with vancomycin till day 4. Abundance of Akkermansia muciniphila of Verrucomicrobia phylum also increased, from day 5 onwards following vancomycin treatment. The time-dependent variation of gut microbiota was associated with increased (i) expression of toll-like receptors and inflammatory genes such as TNF-α, IL-6, and IL-17, (ii) gut barrier permeability and (iii) blood glucose level of the host. The results also showed that (i) transplantation of cecal microbiota from vancomycin-treated day 6 mice to day 3 vancomycin-treated mice helped in restoring blood glucose level in C57BL/6 mice and (ii) short-chain fatty acids like acetate, butyrate and propionate changed with the alteration of gut microbiota to induce differential regulation of host immune response.

Conclusions: The current results revealed that an increase in A. muciniphila led to decreased inflammation and increased rate of glucose tolerance in the host. The treatment, with vancomycin till day 4, increased expression of inflammatory genes. The continuation of vancomycin for two more days reversed the effects. The effects were significantly more in C57BL/6 than BALB/c mice.

Significance and impact of the study: The current study established that the treatment with vancomycin till day 4 increased pathogenic bacteria but day 5 onwards provided significant health-related benefits to the host by increasing A. muciniphila more in C57BL/6 than BALB/c mice.

Keywords: Akkermansia muciniphila; Th1- & Th2-biased mice; cecal microbiota transplantation; gut microbiota; vancomycin.

© 2020 The Society for Applied Microbiology.

PubMed Disclaimer

References

    1. Akira, S. and Hemmi, H. (2003) Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett 85, 85-95.
    1. Al-Sadi, R., Guo, S., Ye, D. and Ma, T.Y. (2013) TNF-α modulation of intestinal epithelial tight junction barrier is regulated by ERK1/2 activation of Elk-1. Am J Pathol 183, 1871-1884.
    1. Andoh, A. (2016) Physiological role of gut microbiota for maintaining human health. Digestion 93, 176-181.
    1. Bendtsen, K.M.B., Krych, L., Sørensen, D.B., Pang, W., Nielsen, D.S., Josefsen, K., Hansen, L.H., Sørensen, S.J. et al. (2012) Gut microbiota composition is correlated to grid floor induced stress and behavior in the BALB/c mouse. PLoS One 7, e46231.
    1. Bernard, L., Vaudaux, P., Vuagnat, A., Stern, R., Rohner, P., Pittet, D., Schrenzel, J., Hoffmeyer, P. et al. (2003) Effect of vancomycin therapy for osteomyelitis on colonization by methicillin-resistant Staphylococcus aureus: lack of emergence of glycopeptide resistance. Infect Control Hosp Epidemiol 24, 650-654.

MeSH terms

Substances

LinkOut - more resources